{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:05:39Z","timestamp":1787843139809,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03898-z","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T09:52:32Z","timestamp":1735033952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case report of an M protein-negative patient with POEMS syndrome associated with renal involvement"],"prefix":"10.1186","volume":"25","author":[{"given":"Wenlin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"3898_CR1","doi-asserted-by":"crossref","unstructured":"Dispenzieri APOEMS, Syndrome. 2019 Update on diagnosis, risk-stratification, and management. American Journal of Hematology. 2019;94(7):812\u2009\u2013\u200927.","DOI":"10.1002\/ajh.25495"},{"issue":"9","key":"3898_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jamaoncol.2021.0586","volume":"7","author":"J Khouri","year":"2021","unstructured":"Khouri J, Nakashima M, Wong S. Update on the diagnosis and treatment of POEMS (polyneuropathy, organomegaly, Endocrinopathy, Monoclonal Gammopathy, and skin changes) syndrome: a review. JAMA Oncol. 2021;7(9):1383\u201391.","journal-title":"JAMA Oncol"},{"issue":"S1","key":"3898_CR3","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.5045\/br.2022.2022001","volume":"57","author":"YR Kim","year":"2022","unstructured":"Kim YR. Update on the POEMS syndrome. Blood Res. 2022;57(S1):S27\u201331.","journal-title":"Blood Res"},{"key":"3898_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1182\/asheducation-2005.1.360","volume":"1","author":"A Dispenzieri","year":"2005","unstructured":"Dispenzieri A. POEMS syndrome. Hematol Am Soc Hematol Educ Program. 2005;1:360\u20137.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"14","key":"3898_CR5","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2169\/internalmedicine.8714-21","volume":"61","author":"K Inoue","year":"2022","unstructured":"Inoue K, Nagai K, Tsukada T, Iwase M, Sakata A, Ueda A, et al. POEMS syndrome with Biclonal Gammopathy and Renal involvement. Intern Med. 2022;61(14):2191\u20136.","journal-title":"Intern Med"},{"issue":"5","key":"3898_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/WCO.0b013e328348e107","volume":"24","author":"M Scarlato","year":"2011","unstructured":"Scarlato M, Previtali SC. POEMS syndrome: the matter-of-fact approach. Curr Opin Neurol. 2011;24(5):491\u20136.","journal-title":"Curr Opin Neurol"},{"key":"3898_CR7","doi-asserted-by":"crossref","unstructured":"Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, et al. Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in crow-fukase (POEMS) syndrome. Muscle Nerve. 1998;11(21):1390\u20137.","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4"},{"issue":"3","key":"3898_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00277-018-03589-4","volume":"98","author":"T He","year":"2019","unstructured":"He T, Zhao A, Zhao H, Cai H, Feng J, Zhang L, et al. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy. Ann Hematol. 2019;98(3):735\u201343.","journal-title":"Ann Hematol"},{"issue":"10","key":"3898_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2169\/internalmedicine.33.583","volume":"33","author":"S Hitoshi","year":"1994","unstructured":"Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Intern Med (Tokyo Japan). 1994;33(10):583\u20137.","journal-title":"Intern Med (Tokyo Japan)"},{"key":"3898_CR10","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1093\/ndt\/14.10.2370","volume":"14","author":"Y Nakamoto","year":"1999","unstructured":"Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transpl. 1999;14:2370\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"3898_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.12998\/wjcc.v12.i3.601","volume":"12","author":"JR Li","year":"2024","unstructured":"Li JR, Feng LY, Li JW, Liao Y, Liu FQ. Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome with dilated cardiomyopathy: a case report. World J Clin Cases. 2024;12(3):601\u20136.","journal-title":"World J Clin Cases"},{"issue":"7","key":"3898_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00277-010-1149-0","volume":"90","author":"J Li","year":"2011","unstructured":"Li J, Zhou D-B, Huang Z, Jiao L, Duan M-H, Zhang W, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol. 2011;90(7):819\u201326.","journal-title":"Ann Hematol"},{"issue":"3","key":"3898_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bjh.12236","volume":"161","author":"J Li","year":"2013","unstructured":"Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol. 2013;161(3):303\u201315.","journal-title":"Br J Haematol"},{"issue":"7","key":"3898_CR14","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","volume":"101","author":"A Dispenzieri","year":"2003","unstructured":"Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101(7):2496\u2013506.","journal-title":"Blood"},{"issue":"1","key":"3898_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hoc.2017.09.011","volume":"32","author":"APOEMS Jaccard","year":"2018","unstructured":"Jaccard APOEMS, Syndrome. Therapeutic options. Hematol Oncol Clin N Am. 2018;32(1):141\u201351.","journal-title":"Hematol Oncol Clin N Am"},{"issue":"6","key":"3898_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ajh.21707","volume":"85","author":"T Stankowski-Drengler","year":"2010","unstructured":"Stankowski-Drengler T, Gertz MA, Katzmann JA, Lacy MQ, Kumar S, Leung N, et al. Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. Am J Hematol. 2010;85(6):431\u20134.","journal-title":"Am J Hematol"},{"issue":"7","key":"3898_CR17","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00277-014-2019-y","volume":"93","author":"C Wang","year":"2014","unstructured":"Wang C, Su W, Zhang W, Di Q, Duan MH, Ji W, et al. Serum immunoglobulin free light chain and heavy\/light chain measurements in POEMS syndrome. Ann Hematol. 2014;93(7):1201\u20136.","journal-title":"Ann Hematol"},{"issue":"2","key":"3898_CR18","first-page":"76","volume":"36","author":"A Fukatsu","year":"1991","unstructured":"Fukatsu A, Tamai H, Nishikawa K, Matsukawa W, Yoshida F, Matsuo S, et al. The kidney disease of crow-fukase (POEMS) syndrome: a clinico-pathological study of four cases. Clin Nephrol. 1991;36(2):76\u201382.","journal-title":"Clin Nephrol"},{"issue":"4","key":"3898_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0272-6386(99)70386-0","volume":"34","author":"M Soubrier","year":"1999","unstructured":"Soubrier M, Sauron C, Souweine B, Larroche C, Wechsler B, Guillevin Lo\u0131\u00a8c, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis. 1999;34(4):633\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"3898_CR20","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2169\/internalmedicine.41.1196","volume":"41","author":"I Endo","year":"2002","unstructured":"Endo I, Mitsui T, Nishino M, Oshima Y, Matsumoto T. Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome. Intern Med (Tokyo Japan). 2002;41(12):1196\u20138.","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"6","key":"3898_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176(6):1248\u201364.","journal-title":"Cell"},{"issue":"8","key":"3898_CR22","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/brain\/awh519","volume":"128","author":"M Scarlato","year":"2005","unstructured":"Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005;128(8):1911\u201320.","journal-title":"Brain"},{"issue":"4","key":"3898_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4161\/org.4.4.7414","volume":"4","author":"H Gerhardt","year":"2008","unstructured":"Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis. 2008;4(4):241\u20136.","journal-title":"Organogenesis"},{"issue":"9","key":"3898_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.yexcr.2012.02.032","volume":"318","author":"M Obeidat","year":"2012","unstructured":"Obeidat M, Obeidat M, Ballermann BJ. Glomerular endothelium: a porous sieve and formidable barrier. Exp Cell Res. 2012;318(9):964\u201372.","journal-title":"Exp Cell Res"},{"key":"3898_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/157016110790226606","volume":"8","author":"E Kent Doi","year":"2010","unstructured":"Kent Doi E, Noiri FT. Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol. 2010;8:122\u20138.","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"3898_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2169\/internalmedicine.46.6246","volume":"46","author":"K Kanai","year":"2007","unstructured":"Kanai K, Kuwabara S, Misawa S, Hattori T. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Intern Med (Tokyo Japan). 2007;46(6):311\u20133.","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"12","key":"3898_CR27","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1136\/jnnp-2012-304874","volume":"84","author":"Y Sekiguchi","year":"2013","unstructured":"Sekiguchi Y, Misawa S, Shibuya K, Nasu S, Mitsuma S, Iwai Y, et al. Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome. J Neurol Neurosurg Psychiatry. 2013;84(12):1346\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3898_CR28","doi-asserted-by":"crossref","unstructured":"Wiszniak S, Schwarz Q. Exploring the Intracrine functions of VEGF-A. Biomolecules. 2021;11(1).","DOI":"10.3390\/biom11010128"},{"key":"3898_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.leukres.2016.09.017","volume":"50","author":"C Wang","year":"2016","unstructured":"Wang C, Huang X-F, Cai Q-Q, Cao X-X, Cai H, Zhou D, et al. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome. Leuk Res. 2016;50:78\u201384.","journal-title":"Leuk Res"},{"issue":"10","key":"3898_CR30","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/bloodadvances.2020001492","volume":"4","author":"S D\u2019Sa","year":"2020","unstructured":"D\u2019Sa S, Thomas M, Lunn MP, Sive J, Keddie S, Weatherill A, et al. High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry. Blood Adv. 2020;4(10):2139\u201342.","journal-title":"Blood Adv"},{"issue":"11","key":"3898_CR31","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1007\/s00277-021-04609-6","volume":"100","author":"XM Gao","year":"2021","unstructured":"Gao XM, Yu YY, Zhao H, Cai H, Zhang L, Cao XX, et al. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome. Ann Hematol. 2021;100(11):2755\u201361.","journal-title":"Ann Hematol"},{"issue":"1","key":"3898_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/bjh.14497","volume":"181","author":"H He","year":"2017","unstructured":"He H, Fu W, Du J, Jiang H, Hou J. Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen. Br J Haematol. 2017;181(1):126\u20138.","journal-title":"Br J Haematol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03898-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T22:02:51Z","timestamp":1735077771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03898-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3898"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03898-z","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient provided written informed consent for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}